Cite
HARVARD Citation
Pourhassan, H. et al. (2022). High prevalence and inferior long‐term outcomes for TP53 mutations in therapy‐related acute lymphoblastic leukemia. American journal of hematology. 97 (5), pp. E171-E173. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pourhassan, H. et al. (2022). High prevalence and inferior long‐term outcomes for TP53 mutations in therapy‐related acute lymphoblastic leukemia. American journal of hematology. 97 (5), pp. E171-E173. [Online].